Literature DB >> 12140228

Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex).

N Cassoux, B Bodaghi, P Lehoang, Y Edel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12140228      PMCID： PMC1771222          DOI： 10.1136/bjo.86.8.940

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

Review 1.  Fungal infections in drug users.

Authors:  C L Leen; R P Brettle
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

2.  Treatment options for candidal endophthalmitis [editoria; comment].

Authors:  M Barza
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

3.  Epidemiological and clinical approach to the study of candidiasis caused by Candida albicans in heroin addicts in the Paris region: analysis of 35 observations.

Authors:  M Mellinger; O De Beauchamp; C Gallien; R Ingold; M J Taboada
Journal:  Bull Narc       Date:  1982 Jul-Dec

4.  Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.

Authors:  B Dupont; E Drouhet
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

5.  Candida endophthalmitis after intravenous drug abuse.

Authors:  G L Aguilar; M S Blumenkrantz; P R Egbert; J P McCulley
Journal:  Arch Ophthalmol       Date:  1979-01

6.  Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy.

Authors:  C Martínez-Vázquez; J Fernández-Ulloa; J Bordón; B Sopeña; J de la Fuente; A Ocampo; M Rubianes
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

7.  The French experience--the pharmacist, general practitioner and patient perspective.

Authors:  J Bouchez; J Vignau
Journal:  Eur Addict Res       Date:  1998       Impact factor: 3.015

8.  Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results.

Authors:  J Bouchez; P Beauverie; D Touzeau
Journal:  Eur Addict Res       Date:  1998       Impact factor: 3.015
  8 in total
  3 in total

Review 1.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

Review 2.  Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review.

Authors:  Nikki Bozinoff; Vitor Tardelli; Dafna Sara Rubin-Kahana; Bernard Le Foll
Journal:  Harm Reduct J       Date:  2022-10-13

3.  Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA.

Authors:  Nongnooch Poowanawittayakom; Anamika Dutta; Shannon Stock; Sunkaru Touray; Richard T Ellison; Stuart M Levitz
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.